| 序号 | 专利名 | 申请号 | 申请日 | 公开（公告）号 | 公开（公告）日 | 发明人 |
|---|---|---|---|---|---|---|
| 21 | 有機セレン材料および有機発光デバイス内でのその使用 | JP2014262199 | 2014-12-25 | JP6067668B2 | 2017-01-25 | チュアンジュン・シャ; レイモンド・クウォン; ビン・マー; チュン・リン |
| 22 | 有機光電素子用化合物及びこれを含む有機光電素子、並びにイメージセンサー及び電子装置 | JP2015229571 | 2015-11-25 | JP2016102117A | 2016-06-02 | 林 宣 晶; 盧 卓 均; 八木 弾生; 朴 敬 培; 尹 晟 榮; 陳 勇 完; 許 哲 準 |
| 【課題】 緑色の波長領域の光を選択的に吸収する有機光電素子用化合物及びこれを含む有機光電素子、並びにイメージセンサー及び電子装置を提供する。 【解決手段】有機光電素子用化合物であって、下記に示す一般式1で表わされる。 【化1】 一般式1で、Ar、X、Ar1、Ar2、R1〜R3に係る説明は、明細書の詳細な説明を参照する。 【選択図】 図1 |
||||||
| 23 | 新規なカルコゲン含有有機化合物およびその用途 | JP2014500745 | 2013-02-20 | JPWO2013125599A1 | 2015-07-30 | 純一 竹谷; 岡本 敏宏; 敏宏 岡本; 太宇人 中西 |
| [課題]合成が容易であり、化学的安定性に優れ、半導体特性(高いキャリア移動度)を有し、かつ溶媒に対する高い溶解性を有する有機化合物を提供する。[解決手段]式(1)または式(2)で表される化合物。[式(1)中、Xは酸素、硫黄またはセレンであり;nは0または1であり;R1〜R3は水素、フッ素、炭素数1〜20のアルキル、アリール、ピリジル、フリル、チエニルまたはチアゾリル等であり、ただし、Xがセレンの場合を除き、全てのR1〜R3が同時に水素であることはなく、また、Xが硫黄であり、かつ全てのR1が同時にブチルであることはない。式(2)中、Xは酸素、硫黄またはセレンであり;nは0または1であり;R1〜R2は水素、炭素数1〜20のアルキル、アリール、ピリジル、フリル、チエニルまたはチアゾリル等であり;ただし、全てのR1〜R2が同時に水素であることはない。] | ||||||
| 24 | Salacinol similar compounds, as well as methods of synthesis Salacinol and Salacinol similar compounds | JP2001550214 | 2001-01-05 | JP5053494B2 | 2012-10-17 | ガバミ、アフマド; ディ． ジョンストン、ブレア; エム． ピント、ブライアン |
| 25 | Heterocyclic fused selenophene monomer | JP2008179482 | 2008-07-09 | JP2009035546A | 2009-02-19 | ZAHN STEFFEN; COSTELLO CARRIE A; MCLAWS MARK |
| <P>PROBLEM TO BE SOLVED: To provide a monomer forming an electrically conductive polymer. <P>SOLUTION: The heterocyclic fused selenophene is expressed by formula (1): in the formula, one or both of X and Y are Se; and R is a substituent group. <P>COPYRIGHT: (C)2009,JPO&INPIT | ||||||
| 26 | Imaging agent | JP2008518267 | 2006-06-19 | JP2009505947A | 2009-02-12 | マーク エム． グッドマン， |
| 本発明は、脳および身体の腫瘍を検出し評価するのに有用である新規なアミノ酸化合物を提供する。 これらの化合物は、腫瘍に迅速に取り込まれ、長期に保持されるという有利な特性を有しており、フッ素−１８、ヨウ素−１２３、ヨウ素−１２４、ヨウ素−１２５、ヨウ素−１３１、臭素−７５、臭素−７６、臭素−７７、臭素−８２、アスタチン−２１０、アスタチン−２１１および他のアスタチンアイソトープなどのハロゲンアイソトープで標識することができる。 これらの化合物は、既知のキレート化錯体を用いたテクネチウムおよびレニウムアイソトープで標識することもできる。 対象に投与されると、本発明で開示の化合物はインビボで、高い特異性と選択性で腫瘍組織と結合する。 | ||||||
| 27 | Mono -, oligo - and Porichieno [3,2-b] thiophenes | JP2007517008 | 2005-04-21 | JP2008504379A | 2008-02-14 | ヴァーグナー，ローベルト; ティアニー，スティーブン; ヒーニー，マーティン; マカロック，イアン |
| 本発明は、新規なモノ−、オリゴ−およびポリチエノ［３，２−ｂ］チオフェン類、それらの半導体または電荷移送物質としての使用、電気光学素子もしくは電子素子、例えば液晶ディスプレイ、光学フィルム、薄膜トランジスタ液晶ディスプレイの有機電界効果トランジスタ（ＦＥＴまたはＯＦＥＴ）およびＲＦＩＤタグ、集積回路（ＩＣ）、フラットパネルディスプレイのエレクトロルミネセント素子、および光起電もしくはセンサー素子における使用、ならびに電界効果トランジスタ、発光素子またはＩＤタグとして前記新規なポリマーを含むもの、に関する。 | ||||||
| 28 | Selenophene anti-tumor agent | JP53839097 | 1997-06-03 | JP2001503381A | 2001-03-13 | アシェンデル，カーティス，エル．; キム，ダリック; チャン，チン―ジャー |
| (57)【要約】 抗腫瘍剤として有用な新規なセレノフェン化合物を説明する。 好ましい化合物は〔構造式Ｉ〕の化合物を含む化合物であり、〔構造式Ｉ〕 式中、R 1とR 2が、 H、CHO、CH 2 OHおよびCH 2 NH 2からなる群から独立に選択され、XとYがSe、S、O、NCH 3およびNHからなる群から独立に選択される。 開示されたセレノフェン化合物を使用する医薬組成物および腫瘍を有する患者の治療のための方法も説明する。 | ||||||
| 29 | (Perfluoroalkyl) dibenzo onium salt | JP2727090 | 1990-02-08 | JP2918598B2 | 1999-07-12 | UMEMOTO TERUO; ISHIHARA SUMI |
| 30 | Polyselenophene, its production, and its use | JP25579598 | 1998-09-09 | JPH11152323A | 1999-06-08 | MOEHWALD HELMUT DR; BELOV VLADIMIR DR; SCHROF WOLFGANG DR |
| PROBLEM TO BE SOLVED: To obtain a novel polyselenophene having a relatively high conductivity and good mechanical properties as well by reacting 2,5-dihaloselenophene or 2,5-ditriflate selenophene with a selenophene derivative which is substituted by bis(trialkyltin) groups on the carbon atoms adjacent to the selenium atom. SOLUTION: This is a polyselenophene comprising one or plural types of structural units of formulas I and/or II (wherein X and Y are each H, a 1-22C alkyl, a 1-22C alkoxyl, a 1-22C alkyloxyalkyl, a 1-22C acyl, a 1-22C thioacyl, a 1-22C thioacyloxy, a 5-8C cycloalkyl, a 6-18C aryl, a 5-8C heterocyclic group, NO 2, or NHR 1, R 1 is H, a 1-22C alkyl, a 1-22C alkoxyl, a 1-22C alkyloxyalkyl, a 1-22C acyl, or a 1-22C thioacyl, and X and Y may be combined with each other to form a carbon-containing ring having a plurality of types of heteroatoms). COPYRIGHT: (C)1999,JPO | ||||||
| 31 | JPH07501497A - | JP50952593 | 1992-11-20 | JPH07501497A | 1995-02-16 | |
| 32 | Synthetic polymer composition containing charge transfer complex, its preparation and its use | JP2338993 | 1993-01-20 | JPH05247257A | 1993-09-24 | PEETAA CHIETOKUTSUCHI |
| PURPOSE: To obtain polymer composition, which do not corrode a metallic workpiece and which are useful as an electric conductor, an anti-static molded product and the like, by constituting the polymer compositions of a certain polymer and a specific charge transfer complex. CONSTITUTION: This composition comprises a thermosetting, thermoplastic or structurally crosslinked polymer and a charge transfer complex represented by formula I {wherein A is a compd. represented by formula II [in which, R is H, a 1-4C alkyl or taken together with the adjacent R to form -(CH 2) 3- or -(CH 2) 4-; R 1 is H or a 1-4C alkyl; X 1 is N-CN; and X 2-4 are each 0 or X 1] or its mixture; B is a compd. represented by formula III or IV [wherein R 2-5 are each H, a 1-18C-(Z 1) n-, phenyl-(Z 1) n-, benzyl-(Z 1) n-, or the like (in which, Z 1 is S or Se; and n is 0 or 1); Y 1-2 are each Z 1; Z is Z 1 or NR 7 (in which, R 7 is H, a 1-6C alkyl, phenyl or benzyl); and R 6 is H, a 1-4C alkyl, phenyl or benzyl]} in the form of a network of crystal needles in the polymer matrix. COPYRIGHT: (C)1993,JPO | ||||||
| 33 | Purification of tellurapyrylium dye | JP16584190 | 1990-06-26 | JPH03115469A | 1991-05-16 | MAIKERU REI DETEI |
| PURPOSE: To efficiently purify the title dye by bringing a soln. containing a specific dye having a tellurapyrylium nucleus at one end of a methine type bridge and an analogue into contact with halogen to form a tellurium derivative of the dye and fractionally precipitating this derivative to reduce the same by a reducing agent to reproduce the dye. CONSTITUTION: A soln. containing an asymmetric tellurapyrylium dye (e.g. formula I) having a tellurapyrylium nucleus at one end of a methine type bridge and having a pyranyl nucleus, a thiapyranyl nucleus or a selenapyranyl nucleus at the other end of the bridge and a symmetric pyrylium, thiapyrylium, selenapyrylium or tellurapyrylium analogue (e.g. formula II) of the dye is prepared to be brought into contact with halogen to form a tellulium (IV) derivative of asymmetric tellurapyrylium dye and this derivative is fractionally precipitated to be precipitated from the reaction mixture and impurities are left in the soln. Next, the precipitated derivative is reduced by a reducing agent to reproduce the dye to obtain high purity asymmetric tellurapyrylium dye. COPYRIGHT: (C)1991,JPO | ||||||
| 34 | Substituted flavonoid compound, its salt, its production and medicine containing them | JP8783889 | 1989-04-06 | JPH026473A | 1990-01-10 | FUIRITSUPU BURIETSUTO; JIINNJIYAKUE BERUSERON; FURANSOWA KOROONE |
| NEW MATERIAL: A compd. represented by formula I [wherein X is N, O, Se or S(O) n (n; 0-2), R 1 is H, alkyl, phenyl or naphthyl, R 2 is H, phenyl, OH or alkyl, R 3 and R 4 are H, alkyl, OH, alkoxy or halogen, R 5 is H, alkyl, CN or COOR 10 (wherein R 10 is H or alkyl), R 6 is H, alkyl, alkylene-CN or COOR 10 and R 7 is CO-alkyl, S-alkyl, SH or S-CO-alkyl] and its salt. EXAMPLE: Oxo-1-phenyl-3-(1H)-naphtho(2,1-b)-pyran-5-acetic acid. USE: An anti-cancer drug and a treatment agent of a disease associated with immune abnormality. PROCESS: For example, a compd. represented by formula II is reacted with an alkaline nitrile component and the reaction product is hydrolyzed to obtain a compd. represented by formula III belonging to the compd. represented by the formula I. COPYRIGHT: (C)1990,JPO | ||||||
| 35 | JPS6227071B2 - | JP2746880 | 1980-03-06 | JPS6227071B2 | 1987-06-12 | EDOWAADO MAATEIN INGURAA; UISHUNUBUHAI UITARUBUHAI PATERU; ROBAATO RIIZU SHUMEIKAA |
| 36 | Tellurane type sensitizer for photoconductive composition | JP18948186 | 1986-08-12 | JPS6239585A | 1987-02-20 | MAIKERU REI DETSUTEII; BURUUSU JIYON MAAREI; MAIKERU SUKOTSUTSUAFUABA |
| 37 | Fulvalene derivative | JP4055386 | 1986-02-26 | JPS6230775A | 1987-02-09 | IGUCHI HIROO; SAITO GUNJI; SEKI KAZUHIKO; MORI TAKEHIKO |
| NEW MATERIAL:A compound expressed by formula I (A is S, Se or Te; R is 3W22C alkyl or alkene). USE: A semiconductor. PREPARATION: CS 2 and Na are refluxed in dimethylformamide (DMF) solvent to give a mixture of compounds expressed by formulas II with III, which is then reacted with zinc chloride and tetrabutylammonium bromide to afford a zinc chelate salt. The resultant zinc chelate salt is then reacted with benzoyl chloride and alcoholate, alkylated and alkenylated to give a compound expressed by formula IV, which is then ketonized with mercuric acetate and reacted with triphenylphosphine, etc., to afford the aimed compound expressed by formula I (A is S), etc. COPYRIGHT: (C)1987,JPO&Japio | ||||||
| 38 | Heterofluvaleneedieminalldithilate compounds and their selenium and tellurium analogues | JP2746880 | 1980-03-06 | JPS55151580A | 1980-11-26 | EDOWAADO MAATEIN INGURAA; BUISHIYUNUBUHAI BUITARUBUHAI P; ROBAATO RIIZU SHIYUMEIKAA |
| 39 | 3-SUBSTITUTED TELLUROPHENES AND RELATED COMPOUNDS | US15981257 | 2018-05-16 | US20180351104A1 | 2018-12-06 | Dwight SEFEROS; Ashlee JAHNKE |
| Monomeric 3-substituted tellurophene compounds, as well as their use in the synthesis of oligomeric and/or polymeric compounds consisting of two or more tellurophene-2,5-diyl groups which are covalently linked to each other are disclosed, as is the use of said oligomers and polymers in devices such as diodes and solar cells, electrodes and semiconductors. | ||||||
| 40 | Synthetic method of fused heteroaromatic compound and fused heteroaromatic compound, and intermediate thereof | US15392816 | 2016-12-28 | US10056563B2 | 2018-08-21 | Eigo Miyazaki; Jeong Il Park; Hyun Bum Kang; Eun Kyung Lee |
| A method of synthesizing a fused heteroaromatic compound includes obtaining a first intermediate from a first compound represented by Chemical Formula 1 and a second compound represented by Chemical Formula 2, obtaining a second intermediate including a ring having a chalcogen element from the first intermediate, and obtaining a fused heteroaromatic compound by a cyclization reaction of the second intermediate. | ||||||
QQ群二维码
意见反馈
意见反馈